Nu Skin Enterprises, Inc. (NUS) is likely to register a decline in the top line when it reports third-quarter 2025 earnings on Nov. 6. The Zacks Consensus Estimate for revenues is pegged at $374.2 ...

Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.37 per share a year ago. These ...

Nu Skin plans to focus on strengthening its core business with the rollout of its sales performance compensation plan in several markets and accelerating growth in developing markets including Latin ...

Nu Skin's stock has found long-term technical support after a steep decline, with an attractive valuation and improving free cash flow, making it a potential value play. Q1 2025 earnings beat ...

Nu Skin's valuation appears extremely cheap, trading at low multiples of EBITDA and free cash flow, but the core business is in structural decline. The multi-level marketing model faces existential ...